Scilex (SCLX) Financials: Revenue & Earnings
SCLX$2.09+0.04 +1.95%
$14.70M
Market Cap
-0.04
P/E
4.60
Forward P/E
—
Score
Scilex (SCLX) Financials: Revenue & Earnings
SCLX price $2.09 +0.04 +1.95%
- Ticker
- SCLX
- Price
- $2.09
- Change
- +0.04 +1.95%
- Market cap ?
- $14.70M
- P/E ?
- -0.04
- Forward P/E ?
- 4.60
- Dividend yield ?
- 0.00%
- Beta ?
- 1.79
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 21033000 | 23560000 | 31317000 | 38034000 | 46743000 | 56590000 | 30253000 |
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by…
Fair value
SCLX fair value $19.68. Price $2.09. Price is 89% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 10.02M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 7.03M. Net debt 127.59M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-12-02 | — | -0.08 | — | 17.00M |
| 2026-08-14 | -16.65 | -0.18 | 7.64M | 16.00M |
| 2026-05-20 | -4.76 | -0.21 | 8.61M | 15.00M |
| 2026-04-10 | -4.60 | -0.29 | 4.79M | 12.10M |
| 2025-11-14 | -13.80 | -13.80 | 10.56M | 10.56M |
| 2025-08-12 | -4.62 | -0.57 | 9.90M | 26.25M |
| 2025-05-14 | -2.26 | -4.20 | 5.00M | 5.00M |
| 2025-03-31 | -0.02 | -0.10 | 14.90M | 17.79M |
| 2025-03-17 | -2.18 | -0.10 | 14.44M | 17.87M |
| 2024-08-13 | -6.29 | -3.65 | 16.40M | 16.17M |
| 2024-05-13 | -9.09 | -4.20 | 10.90M | 10.88M |
| 2024-03-11 | -8.74 | -7.34 | 13.50M | 11.43M |
| 2023-11-14 | -22.03 | -5.94 | 10.11M | 11.37M |
| 2023-08-11 | -5.59 | — | 12.60M | — |
| 2023-05-12 | -0.22 | — | 10.58M | — |
| 2023-03-07 | -0.16 | — | 11.92M | — |
Dividends
Yield 0.00%. Payout ratio —. Frequency —.
Safety score 24/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-03 | SCLX Stock Acquisition JV LLC | Sell | 500.00K | — | — |
| 2026-04-17 | Ma Stephen Hoi | Buy | 650.00K | $1.20 | 780.00K |
| 2026-04-17 | Ji Henry | Sell | 650.00K | $1.20 | 780.00K |
| 2026-04-16 | Ji Henry | Buy | 3.25M | $1.20 | 3.90M |
| 2025-12-30 | Scilex Holding Co | Sell | 9.66M | $0.54 | 5.21M |
| 2025-12-29 | Scilex Holding Co | Sell | 7.31M | $0.66 | 4.79M |
| 2025-12-26 | Scilex Holding Co | Sell | 3.69M | $0.75 | 2.77M |
| 2025-10-08 | Wu Yue Alexander | Buy | 20.00K | $17.58 | 351.60K |
| 2025-10-08 | Ma Stephen Hoi | Buy | 60.00K | $17.58 | 1.05M |
| 2025-10-08 | Chun Jay | Buy | 20.00K | $17.58 | 351.60K |
| 2025-10-08 | Ji Henry | Buy | 120.00K | $17.58 | 2.11M |
| 2025-10-08 | Followwill Dorman | Buy | 20.00K | $17.58 | 351.60K |
| 2025-01-21 | SCLX Stock Acquisition JV LLC | Sell | 3.25M | $0.00 | 325 |
| 2025-01-16 | SCLX Stock Acquisition JV LLC | Sell | 779.37K | $0.00 | 78 |
| 2025-01-02 | SCLX Stock Acquisition JV LLC | Sell | 5.00M | $0.00 | 500 |
| 2024-12-18 | SHAH JAISIM | Buy | 30.00K | $0.46 | 13.80K |
| 2024-12-16 | Chun Jay | Buy | 100.00K | $0.50 | 50.45K |
| 2024-12-16 | Followwill Dorman | Buy | 100.00K | $0.50 | 50.45K |
| 2024-12-16 | Wu Yue Alexander | Buy | 100.00K | $0.50 | 50.45K |
| 2024-10-31 | Ji Henry | Buy | 8.89K | $0.94 | 8.35K |
| 2024-10-29 | SHAH JAISIM | Buy | 32.00K | $0.99 | 31.67K |
| 2024-10-18 | Followwill Dorman | Buy | 1.00K | $0.99 | 990 |
| 2024-10-18 | Chun Jay | Buy | 5.00K | $0.95 | 4.75K |
| 2024-10-17 | Wu Yue Alexander | Buy | 20.00K | $0.95 | 18.99K |
| 2024-10-17 | Lemus David | Buy | 2.00K | $0.90 | 1.80K |
| 2024-10-17 | Ji Henry | Buy | 10.00K | $0.97 | 9.71K |
| 2024-10-16 | SHAH JAISIM | Buy | 30.00K | $0.99 | 29.75K |
| 2024-10-16 | Ma Stephen Hoi | Buy | 6.70K | $0.97 | 6.50K |
| 2024-08-16 | Navani Annu | Buy | 250.00K | $1.23 | 307.50K |
| 2024-07-21 | Navani Annu | Other | 0 | — | — |
| 2024-06-26 | Followwill Dorman | Sell | 1.00K | $1.37 | 1.37K |
| 2024-06-26 | Followwill Dorman | Buy | 1.00K | $1.37 | 1.37K |
| 2024-06-20 | Wu Yue Alexander | Sell | 5.00K | $1.41 | 7.05K |
| 2024-06-20 | Wu Yue Alexander | Buy | 5.00K | $1.41 | 7.05K |
| 2024-06-20 | Ma Stephen Hoi | Sell | 2.00K | $1.41 | 2.82K |
| 2024-06-20 | Ma Stephen Hoi | Buy | 2.00K | $1.41 | 2.82K |
| 2024-06-20 | Chun Jay | Sell | 5.00K | $1.41 | 7.05K |
| 2024-06-20 | Chun Jay | Buy | 5.00K | $1.41 | 7.05K |
| 2024-06-20 | SHAH JAISIM | Sell | 14.00K | $1.73 | 24.22K |
| 2024-06-20 | SHAH JAISIM | Buy | 14.00K | $1.73 | 24.22K |
| 2024-06-18 | Ji Henry | Buy | 6.00K | $1.41 | 8.46K |
| 2024-06-18 | Ji Henry | Sell | 6.00K | $1.41 | 8.46K |
| 2024-06-14 | SHAH JAISIM | Sell | 33.33K | $1.41 | 47.00K |
| 2024-06-14 | SHAH JAISIM | Buy | 33.33K | $1.41 | 47.00K |
| 2024-05-17 | Ji Henry | Buy | 50.00K | $0.88 | 43.98K |
| 2024-05-17 | Chun Jay | Buy | 57.50K | $0.90 | 51.64K |
| 2024-05-17 | SHAH JAISIM | Buy | 56.94K | $0.92 | 52.10K |
| 2024-05-17 | Ma Stephen Hoi | Buy | 14.14K | $0.88 | 12.44K |
| 2024-05-16 | SHAH JAISIM | Buy | 83.06K | $0.84 | 69.85K |
| 2024-03-15 | Lemus David | Buy | 100.00K | $1.37 | 137.00K |
| 2024-03-15 | Followwill Dorman | Buy | 100.00K | $1.37 | 137.00K |
| 2023-10-04 | Ji Henry | Buy | 200.00K | $1.41 | 282.00K |
| 2023-10-04 | SHAH JAISIM | Buy | 200.00K | $1.41 | 282.00K |
| 2023-10-04 | Wu Yue Alexander | Buy | 250.00K | $1.41 | 352.50K |
| 2023-10-04 | Chun Jay | Buy | 250.00K | $1.41 | 352.50K |
| 2023-10-04 | Ma Stephen Hoi | Buy | 150.00K | $1.41 | 211.50K |
| 2023-09-22 | Ma Stephen Hoi | Sell | 0 | — | — |
| 2023-09-22 | Ji Henry | Sell | 0 | — | — |
| 2023-09-22 | Ji Henry | Other | 0 | — | — |
| 2023-09-22 | Ji Henry | Other | 0 | — | — |
| 2023-09-22 | Ji Henry | Other | 0 | — | — |
| 2023-09-22 | Ji Henry | Other | 0 | — | — |
| 2023-09-22 | Ji Henry | Sell | 232.24K | $1.73 | 401.77K |
| 2023-09-22 | Ji Henry | Sell | 9.00M | $8.08 | 72.72M |
| 2023-09-22 | Ji Henry | Sell | 1.80M | $1.73 | 3.11M |
| 2023-09-22 | SCLX Stock Acquisition JV LLC | Sell | 0 | — | — |
| 2023-09-22 | SCLX Stock Acquisition JV LLC | Sell | 490.62K | $11.50 | 5.64M |
| 2023-09-22 | Wu Yue Alexander | Sell | 404.10K | $1.73 | 699.09K |
| 2023-09-22 | Chun Jay | Sell | 0 | — | — |
| 2023-09-22 | Ma Stephen Hoi | Sell | 0 | — | — |
| 2023-09-22 | Ma Stephen Hoi | Sell | 50.51K | $1.73 | 87.39K |
| 2023-09-22 | Ma Stephen Hoi | Sell | 294.11K | $8.08 | 2.38M |
| 2023-09-22 | Ma Stephen Hoi | Sell | 55.89K | $8.08 | 451.62K |
| 2023-09-22 | Ma Stephen Hoi | Sell | 67.35K | $1.73 | 116.51K |
| 2023-09-21 | Sorrento Therapeutics, Inc. | Sell | 60.07M | $10.00 | 600.69M |
| 2023-09-21 | Sorrento Therapeutics, Inc. | Sell | 4.49M | $11.50 | 51.64M |
| 2023-03-17 | Ji Henry | Buy | 2.73K | $8.60 | 23.48K |
| 2023-01-19 | Sorrento Therapeutics, Inc. | Sell | 73.74M | — | — |
| 2023-01-17 | Followwill Dorman | Buy | 250.00K | — | — |
| 2023-01-17 | Thompson Tommy G | Buy | 250.00K | — | — |
| 2023-01-17 | Lee Tien-Li | Buy | 250.00K | — | — |
| 2023-01-17 | Hamill Laura | Buy | 250.00K | — | — |
| 2023-01-17 | Lemus David | Buy | 250.00K | — | — |
| 2023-01-17 | CZEREPAK ELIZABETH | Buy | 350.00K | — | — |
| 2023-01-17 | SHAH JAISIM | Buy | 1.70M | — | — |
| 2023-01-17 | Ji Henry | Buy | 9.00M | — | — |
| 2022-12-02 | Sorrento Therapeutics, Inc. | Buy | 224.84K | $0.35 | 78.85K |
| 2022-11-25 | Sorrento Therapeutics, Inc. | Buy | 46.17K | $0.44 | 20.20K |
| 2022-11-23 | Sorrento Therapeutics, Inc. | Buy | 442.83K | $0.40 | 175.67K |
| 2022-11-22 | Sorrento Therapeutics, Inc. | Buy | 672.77K | $0.23 | 152.05K |
| 2022-11-10 | Woo Pei Wei | Other | 0 | — | — |
| 2022-11-10 | Myint Steve | Other | 0 | — | — |
| 2022-11-10 | Kaji Suneel G | Other | 0 | — | — |
| 2022-11-10 | Vickers Venture Fund VI Pte Ltd | Sell | 5.26M | — | — |
| 2022-11-10 | Vickers Venture Fund VI Pte Ltd | Sell | 578.16K | — | — |
| 2022-11-10 | Sorrento Therapeutics, Inc. | Buy | 307.30K | — | — |
| 2022-11-10 | Sorrento Therapeutics, Inc. | Buy | 2.80M | — | — |
| 2022-11-10 | Hamill Laura | Other | — | — | — |
| 2022-11-10 | Hamill Laura | Other | 0 | — | — |
| 2022-11-10 | SHAH JAISIM | Sell | 1.57M | $1.73 | 2.71M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 71, holders +1 vs prior quarter. Ownership 10.20%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 301.29K | 37.24K | +14.10% | 2.35M |
| BLACKROCK, INC. | 109.42K | 6.62K | +6.44% | 853.45K |
| VANGUARD FIDUCIARY TRUST CO | 45.82K | 6.16K | +15.54% | 357.41K |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 41.16K | 41.16K | New | 321.07K |
| STATE STREET CORP | 35.38K | 0 | 0.00% | 275.93K |
| UBS GROUP AG | 33.38K | 26.91K | +416.02% | 260.33K |
| RENAISSANCE TECHNOLOGIES LLC | 33.06K | -3.80K | -10.31% | 257.90K |
| CITADEL ADVISORS LLC | 27.50K | 27.50K | New | 214.48K |
| PRICE T ROWE ASSOCIATES INC /MD/ | 20.92K | 20.92K | New | 164.00K |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 18.48K | 493 | +2.74% | 144.16K |
| NORTHERN TRUST CORP | 15.05K | 14 | +0.09% | 117.37K |
| MORGAN STANLEY | 4.03K | -7.94K | -66.32% | 31.45K |
| VANGUARD GLOBAL ADVISERS, LLC | 2.94K | 0 | 0.00% | 22.91K |
| OSAIC HOLDINGS, INC. | 2.34K | 2.24K | +2286.73% | 18.24K |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 1.85K | 0 | 0.00% | 14.45K |
| ROYAL BANK OF CANADA | 1.75K | 149 | +9.34% | 14.00K |
| JONES FINANCIAL COMPANIES LLLP | 1.75K | 1.00K | +133.38% | 12.48K |
| LARSON FINANCIAL GROUP LLC | 1.42K | 1.38K | +3278.57% | 11.07K |
| METLIFE INVESTMENT MANAGEMENT, LLC | 1.09K | 0 | 0.00% | 8.50K |
| DEUTSCHE BANK AG\ | 800 | 0 | 0.00% | 6.24K |
| VERSANT CAPITAL MANAGEMENT, INC | 761 | 0 | 0.00% | 5.94K |
| IFP ADVISORS, INC | 576 | 0 | 0.00% | 4.49K |
| MCF ADVISORS LLC | 474 | 0 | 0.00% | 3.70K |
| ACTIVEST WEALTH MANAGEMENT | 302 | 0 | 0.00% | 2.36K |
| KLP KAPITALFORVALTNING AS | 290 | 0 | 0.00% | 2.26K |
Earnings and financials
Scilex Holding Company (SCLX) trades at $2.09, with a market cap of $14.70M and a trailing P/E of -0.04. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 21033000 | 23560000 | 31317000 | 38034000 | 46743000 | 56590000 | 30253000 |
Insights · Dividends · Forecast · Financials · Learn